Enlivex (ENLV) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Enlivex Therapeutics Ltd. is inviting investors to an informative webinar on June 25, 2024, featuring updates on the company’s breakthrough immunotherapy product, Allocetra™, and insights from their CEO, Dr. Oren Hershkovitz. The webinar will highlight promising Phase I/II trial results for Allocetra™, showing significant pain reduction in severe knee osteoarthritis patients, and will also cover the company’s clinical program progress and financial status after a recent funding round.
For further insights into ENLV stock, check out TipRanks’ Stock Analysis page.
